Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retarded intracellular lipid transport associated with reduced expression of Cdc42, a member of Rho-GTPases, in human aged skin fibroblasts: a possible function of Cdc42 in mediating intracellular lipid transport.
Tsukamoto K, Hirano K, Yamashita S, Sakai N, Ikegami C, Zhang Z, Matsuura F, Hiraoka H, Matsuyama A, Ishigami M, Matsuzawa Y. Tsukamoto K, et al. Among authors: matsuzawa y. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1899-904. doi: 10.1161/01.atv.0000036080.42391.33. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426222
Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--.
Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T; Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan. Maruyama T, et al. Among authors: matsuzawa y. J Atheroscler Thromb. 2004;11(3):131-45. doi: 10.5551/jat.11.131. J Atheroscler Thromb. 2004. PMID: 15256764 Free article.
Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan.
Bujo H, Takahashi K, Saito Y, Maruyama T, Yamashita S, Matsuzawa Y, Ishibashi S, Shionoiri F, Yamada N, Kita T; Research Committeon Primary Hyperlipidemia of the Ministry of Health, Labour, and Welfare of Japan. Bujo H, et al. Among authors: matsuzawa y. J Atheroscler Thromb. 2004;11(3):146-51. doi: 10.5551/jat.11.146. J Atheroscler Thromb. 2004. PMID: 15256765 Free article.
Adiponectin: a key adipocytokine in metabolic syndrome.
Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Okamoto Y, et al. Among authors: matsuzawa y. Clin Sci (Lond). 2006 Mar;110(3):267-78. doi: 10.1042/CS20050182. Clin Sci (Lond). 2006. PMID: 16464169 Review.
Where are we with probucol: a new life for an old drug?
Yamashita S, Matsuzawa Y. Yamashita S, et al. Among authors: matsuzawa y. Atherosclerosis. 2009 Nov;207(1):16-23. doi: 10.1016/j.atherosclerosis.2009.04.002. Epub 2009 Apr 11. Atherosclerosis. 2009. PMID: 19457483 Review.
Residual macrovascular risk in 2013: what have we learned?
Fruchart JC, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM Jr, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés JM, Monfil CC, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P; Residual Risk Reduction Initiative (R3i). Fruchart JC, et al. Among authors: matsuzawa y. Cardiovasc Diabetol. 2014 Jan 24;13:26. doi: 10.1186/1475-2840-13-26. Cardiovasc Diabetol. 2014. PMID: 24460800 Free PMC article. Review.
Did we abandon probucol too soon?
Yamashita S, Masuda D, Matsuzawa Y. Yamashita S, et al. Among authors: matsuzawa y. Curr Opin Lipidol. 2015 Aug;26(4):304-16. doi: 10.1097/MOL.0000000000000199. Curr Opin Lipidol. 2015. PMID: 26125504 Review.
1,295 results